Li Zheng
No.518 East Wuzhong Road
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Utility of 18F-Florzolotau PET as a prognostic and monitoring biomarker in a memory clinic cohort.
Journal: Alzheimer's research & therapy
Published: September 15, 2025
Clinical features, biomarker profiles, and neuroimaging characteristics in patients from memory clinic in china: The Shanghai Memory Study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 26, 2025
Incremental value of amyloid PET in a tertiary memory clinic setting in China.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 08, 2023
The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study.
Journal: Alzheimer's research & therapy
Published: June 20, 2023
Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
Journal: Translational neurodegeneration
Published: February 19, 2023
A Pilot Study of Near-Infrared Light Treatment for Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: November 14, 2022
Structural, static, and dynamic functional MRI predictors for conversion from mild cognitive impairment to Alzheimer's disease: Inter-cohort validation of Shanghai Memory Study and ADNI.
Journal: Human brain mapping
Published: September 30, 2022
Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer's Disease: Shanghai Aging Study and Shanghai Memory Study.
Journal: Nutrients
Published: July 26, 2022
The Relationship Between Low-Density Lipoprotein Cholesterol and Progression of Mild Cognitive Impairment: The Influence of rs6859 in PVRL2.
Journal: Frontiers in genetics
Published: November 27, 2021
Development of a Plasma Biomarker Diagnostic Model Incorporating Ultrasensitive Digital Immunoassay as a Screening Strategy for Alzheimer Disease in a Chinese Population.
Journal: Clinical chemistry
Published: May 12, 2021
Last Updated: 09/26/2026